查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715477

精準醫療市場（按產品類型、應用和最終用戶分類）－2025-2030 年全球預測

Precision Medicine Market by Product Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

精準醫療市場規模預計在 2024 年達到 1,405.4 億美元，2025 年將成長至 1,559 億美元，複合年成長率為 11.44%，到 2030 年將達到 2,692 億美元。

主要市場統計數據
基準年2024年 1405.4億美元
預計2025年 1559億美元
預測年份 2030 2692億美元
複合年成長率（%） 11.44%

精準醫療代表了醫療保健提供方式的模式轉移，將個別患者置於治療策略的核心。基因組學、數位健康和​​生物技術的最新趨勢正在推動針對個別患者的治療方法和診斷方法的發展。本報告提供了詳細的執行摘要，深入探討了精準醫療的當前和未來前景，揭示了將重新定義該行業的新興趨勢和機會。

分析的重點不僅在於突顯治療和診斷的突破，還在於探索這個快速發展領域背後的社會經濟和監管因素。透過這樣做，該報告旨在為行業專家和決策者提供對行業格局的全面了解，以更好地理解市場方向以及組織在探索這一複雜領域時應考慮的步驟。

這項全面概況呼籲採取平衡前沿研究與實際實施的創新策略。當我們經歷各種轉型轉變、細分洞察和區域動態時，我們清楚地認知到精準醫療不僅是一種趨勢，而且是全球醫療保健系統的根本重組。

精準醫療的變革：診斷與治療的新時代

精準醫療領域正在轉變，這將改變疾病的診斷和治療方式。高通量基因組定序的採用、分子診斷的進步以及人工智慧在臨床決策中的整合，為更精確、更及時的干涉鋪平了道路。這種轉變的特點是更加重視個人化治療計劃，將遺傳、環境和生活方式因素考慮在內，從而可以更有效地根據個別患者情況量身定做治療方案。

在全球市場，將綜合數據分析與臨床研究結合的趨勢明顯。這種整合正在創建一個強大的生態系統，其中即時數據可以為治療選擇提供資訊，增強臨床試驗，並最終實現更高效的醫療服務。這一轉變得益於對數位健康平台和精準診斷的大量投資，標誌著從傳統的一刀切方法轉向更以患者為中心的解決方案的決定性轉變。

技術進步也使得預測分析方法更加複雜，這對於管理需要持續監測和介入的慢性疾病和狀況至關重要。為了適應這些轉變，醫療保健提供者越來越依賴數據主導的洞察力來最佳化護理途徑，從而降低成本並改善患者的治療效果。這種向精準化的轉變不僅重新定義了治療通訊協定，而且還開創了預防醫學的新時代，重點是早期發現和量身定做的治療策略。

精準醫療市場發展的關鍵細分洞察

精準醫療市場根據產品類型、應用和最終用戶進行複雜細分，每個細分領域都為整體情況帶來各自的維度。深入研究產品類型，可以發現市場研究涉及診斷、軟體和數據分析以及治療學。診斷是精準醫療的重要支柱，涵蓋多種方法，包括伴同性診斷、基因檢測、液態切片、分子診斷和就地檢驗。這些方法透過詳細了解患者的分子特徵，有助於早期發現疾病並確定治療方案。

同時，我們透過幾種先進的治療方法對該市場上的治療藥物進行了分析。這包括細胞療法、基因療法、免疫療法、蛋白質替代療法、基於 RNA 的療法、標靶治療等。治療領域強調個人化治療的重要性，並著重於精確針對各種疾病背後的基因異常的治療方法。軟體和數據分析進一步補充了這些方法，使得複雜資料集的聚合和解釋成為可能，從而增強診斷和治療過程。

從應用細分來看，精準醫療在治療各類嚴重疾病方面取得了重大進展。該市場涵蓋的應用領域包括自體免疫疾病、心臟病學、感染疾病、神經病學、腫瘤學、罕見疾病、遺傳疾病、呼吸系統疾病等。如此廣泛的應用凸顯了精準醫療的多功能性和不斷擴大的潛力，可以解決不同患者群體中通用和複雜的健康問題。

透過對最終用戶（包括生物製藥和生物技術公司、診斷實驗室、醫院和診所以及研究機構）的調查，細分分析得到進一步豐富。每個部分都在生態系統中發揮關鍵作用，積極推動創新並加速新的精準醫療解決方案的臨床整合。綜合起來，這些細分凸顯了市場的相互聯繫，一個領域的進步往往會催化其他領域的進步，最終刺激精準醫療的整體發展動能。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 慢性病增多，個人化治療方案需求增加
      • 提高病患和醫療專業人員對精準醫療益處的認知
      • 政府加強以及公共與私人資金投入，推動科技進步
    • 限制因素
      • 精準醫療開發成本高，缺乏標準化通訊協定和指南
    • 機會
      • 將人工智慧融入精準醫療，改善病患診斷和治療
      • 市場供應商與研究機構合作推動精準醫療
    • 任務
      • 對病患隱私以及個人和健康資訊保密性的擔憂
  • 市場區隔分析
    • 產品類型：由於在找出疾病的分子和遺傳基礎方面發揮重要作用，因此提高了診斷利用率
    • 應用：精準醫療廣泛應用於腫瘤學，因為它可以根據個人基因、分子和臨床特徵來客製化治療方法。
    • 最終用戶：生物製藥和生技公司採用精準醫療來開發標靶治療
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章 精準醫療市場（依產品類型）

  • 診斷
    • 伴同性診斷
    • 基因檢測
    • 液態生物檢體
    • 分子診斷
    • 就地檢驗
  • 軟體和數據分析
  • 治療
    • 細胞療法
    • 基因治療
    • 免疫療法
    • 蛋白質替代療法
    • 基於RNA的治療方法
    • 標靶治療

第7章 精準醫療市場（依應用）

  • 自體免疫疾病
  • 心臟病學
  • 感染疾病
  • 神經病學
  • 腫瘤學
  • 罕見疾病和遺傳疾病
  • 呼吸系統疾病

第8章 精準醫療市場（依最終使用者）

  • 生物製藥和生物技術公司
  • 診斷實驗室
  • 醫院和診所
  • 研究組織

9. 美洲精準醫療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太精準醫療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲精準醫療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • AbbVie Inc.
  • Amgen Inc.
  • Aranscia, LLC
  • AstraZeneca PLC
  • biocrates life sciences ag
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Caris Life Sciences
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • Guardant Health, Inc.
  • healthOme, Inc.
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Johnson & Johnson
  • Laboratory Corporation of America Holdings
  • Medtronic PLC
  • Merck KGaA
  • N-Power Medicine, Inc.
  • Natera Inc.
  • NeoGenomics, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Precision Medicine Group, LLC
  • QIAGEN NV
  • Quest Diagnostics Incorporated
  • Sanofi SA
  • Strata Oncology, Inc.
  • Tempus AI, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • ZS Associates, Inc.
Product Code: MRR-030EE48515D0

The Precision Medicine Market was valued at USD 140.54 billion in 2024 and is projected to grow to USD 155.90 billion in 2025, with a CAGR of 11.44%, reaching USD 269.20 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 140.54 billion
Estimated Year [2025] USD 155.90 billion
Forecast Year [2030] USD 269.20 billion
CAGR (%) 11.44%

Precision medicine represents a paradigm shift in the way healthcare is delivered, placing the individual patient at the center of treatment strategies. Over recent years, advances in genomics, digital health, and biotechnology have converged to enable the development of therapies and diagnostics that are tailored to the unique characteristics of each patient. This report provides an in-depth executive summary that delves into the current state and future prospects of precision medicine, uncovering the emerging trends and opportunities that are set to redefine the industry.

The focus of the analysis is not only to highlight the breakthroughs in treatment and diagnostics but also to explore the socio-economic and regulatory factors that underpin this rapidly evolving field. In doing so, the report aims to equip industry experts and decision-makers with a comprehensive view of the landscape, fostering a deeper understanding of where the market is headed and what steps organizations should consider when navigating this complex arena.

This comprehensive overview serves as a call for innovative strategies that balance cutting-edge research with pragmatic execution. As we journey through the various transformative shifts, segmentation insights, and regional dynamics, it becomes clear that precision medicine is not merely a trend, but a fundamental reimagining of healthcare systems around the world.

Transformative Shifts in Precision Medicine: A New Era of Diagnosis and Treatment

The landscape of precision medicine is undergoing transformative shifts that are revolutionizing how diseases are diagnosed and treated. The adoption of high-throughput genomic sequencing, advancements in molecular diagnostics, and the integration of artificial intelligence in clinical decision-making are paving the path for more accurate and timely interventions. These shifts are characterized by an increased emphasis on personalized treatment plans that consider genetic, environmental, and lifestyle factors, leading to therapies that can be more effectively matched to individual patient profiles.

Across the global market, there is a significant move towards integrating comprehensive data analytics with clinical research. This integration is fostering a robust ecosystem where real-time data informs treatment choices, enhances clinical trials, and ultimately leads to more efficient healthcare delivery. The evolution is supported by substantial investments in digital health platforms and precision diagnostics, signaling a definitive change from traditional one-size-fits-all approaches to more patient-centric solutions.

Technological advancements are also enabling more sophisticated approaches in predictive analytics, which are crucial in managing chronic diseases and conditions that require ongoing monitoring and intervention. As healthcare providers adapt to these transformative shifts, they are increasingly relying on data-driven insights to optimize care pathways, thereby reducing costs and improving patient outcomes. This shift towards precision is not only redefining treatment protocols but is also launching an era of preventative care where the primary focus is on early detection and tailored therapeutic strategies.

Key Segmentation Insights in the Evolving Precision Medicine Market

The market for precision medicine is intricately segmented by product type, application, and end user, each bringing unique dimensions to the overall landscape. A deep-dive into product type reveals that the market is studied across diagnostics, software and data analytics, and therapeutics. Diagnostics, an essential pillar in precision medicine, spans multiple approaches such as companion diagnostics, genetic testing, liquid biopsy, molecular diagnostics, and point-of-care testing. These methods are instrumental in early disease detection and guiding treatment decisions by providing a granular understanding of a patient's molecular profile.

In parallel, therapeutics in the market are analyzed across several advanced treatment modalities. These include cell therapy, gene therapy, immunotherapy, protein replacement therapy, RNA-based therapy, and targeted therapy. The therapeutic segment underscores the importance of personalized treatment by focusing on modalities that precisely target the underlying genetic anomalies of various diseases. Software and data analytics further complement these approaches, enabling the aggregation and interpretation of complex datasets to bolster both diagnostic and therapeutic processes.

When considering the segmentation based on application, precision medicine has made significant inroads in addressing a range of critical conditions. The market encompasses applications spanning autoimmune diseases, cardiology, infectious diseases, neurology, oncology, rare and genetic disorders, as well as respiratory diseases. This broad spectrum of applications highlights the versatility and expansive potential of precision medicine in addressing both common and complex health issues across a diverse array of patient populations.

The segmentation analysis is further enriched by an exploration of end users, which include biopharmaceutical and biotechnology companies, diagnostic laboratories, hospitals and clinics, as well as research institutes. Each of these segments plays a vital role in the ecosystem, actively driving innovation and facilitating the integration of novel precision medicine solutions into clinical practice. Collectively, these segmentation insights illustrate the interconnected nature of the market, where advancements in one segment often catalyze progress in others, ultimately fueling the overall momentum of precision medicine.

Based on Product Type, market is studied across Diagnostics, Software & Data Analytics, and Therapeutics. The Diagnostics is further studied across Companion Diagnostics, Genetic Testing, Liquid Biopsy, Molecular Diagnostics, and Point-of-Care Testing. The Therapeutics is further studied across Cell Therapy, Gene Therapy, Immunotherapy, Protein Replacement Therapy, RNA-Based Therapy, and Targeted Therapy.

Based on Application, market is studied across Autoimmune Diseases, Cardiology, Infectious Diseases, Neurology, Oncology, Rare & Genetic Disorders, and Respiratory Diseases.

Based on End User, market is studied across Biopharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Hospitals & Clinics, and Research Institutes.

Key Regional Insights: Global Dynamics Shaping the Precision Medicine Arena

The regional landscape of the precision medicine market provides a multifaceted view of how various economic, regulatory, and cultural factors drive innovation and adoption. In the Americas, significant investment in biotechnology research coupled with robust healthcare infrastructure has positioned the region as a leader in precision medicine innovation. The Americas continue to play a pivotal role in pioneering clinical trials and advanced research initiatives, setting benchmarks for other regions on both efficacy and patient safety protocols.

Europe, Middle East and Africa (EMEA) also present a dynamic environment characterized by collaborative research frameworks and a strong emphasis on regulatory harmonization. The region benefits from an established network of research institutions and healthcare facilities that often engage in cross-border partnerships, providing a fertile ground for the development and implementation of advanced precision diagnostic tools and therapies. Simultaneously, the Asia-Pacific region is emerging as a significant player, bolstered by rapid advancements in technology and increasing investments in healthcare innovation. This region has seen a surge in both clinical and commercial activities related to precision medicine, driven by the growing demand for healthcare solutions that cater to diverse genetic backgrounds and emerging health challenges.

These regional insights underscore the importance of localized as well as collaborative global strategies. As precision medicine continues to evolve, stakeholders in each region are increasingly leveraging their unique strengths-be it research expertise, regulatory diligence, or market agility-to contribute to a globally interconnected healthcare ecosystem. This confluence of regional dynamics is fostering innovations that not only enhance patient care on a local level but also contribute to a broader understanding of disease management and therapeutic interventions worldwide.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Landscape of Precision Medicine

Several prominent companies are at the forefront of driving innovation in precision medicine. Major industry players such as AbbVie Inc., Amgen Inc., and AstraZeneca PLC are championing new drug discoveries and targeted therapies, while smaller innovative firms like Aranscia, LLC and biocrates life sciences ag are contributing novel approaches to diagnostic and analytics technologies. In addition, bioMerieux S.A. and Bristol-Myers Squibb Company are making significant strides in molecular diagnostics and advanced therapeutic solutions.

Other notable entities such as Caris Life Sciences and Exact Sciences Corporation have established themselves as key contributors in the realm of companion diagnostics and early cancer detection. Leading pharmaceutical giants like F. Hoffmann-La Roche AG, Gilead Sciences, Inc., and Johnson & Johnson are continually investing in breakthrough research and development, further underscoring the importance of precision medicine as an integral component of modern healthcare. Organizations like Laboratory Corporation of America Holdings and Illumina, Inc. exemplify the critical role that diagnostic laboratories and genomic sequencing technologies play in supporting personalized treatment regimens.

The landscape is further enriched by the participation of Medtronic PLC, Merck KGaA, and N-Power Medicine, Inc., who are advancing not only therapeutic interventions but also integrated care solutions that harness both hardware and software innovations. Natera Inc., NeoGenomics, Inc., Novartis AG, and Pfizer, Inc. continue to lead in marrying clinical breakthroughs with large-scale commercial application, while companies such as Precision Medicine Group, LLC, QIAGEN N.V., and Quest Diagnostics Incorporated emphasize the importance of robust data analytics in realizing the full potential of precision therapies. Other influential organizations including Sanofi SA, Strata Oncology, Inc., Tempus AI, Inc., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and ZS Associates, Inc. are making strategic investments that resonate with the evolving demand for patient-specific care modalities.

Collaboration and strategic partnerships among these companies are driving the market forward, creating synergies that not only foster innovation but also enhance the accessibility and impact of precision medicine solutions globally. Their collective efforts are pivotal in advancing a healthcare model that is distinctly tailored to individual patient needs while pushing the boundaries of what is clinically possible.

The report delves into recent significant developments in the Precision Medicine Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Aranscia, LLC, AstraZeneca PLC, biocrates life sciences ag, bioMerieux S.A., Bristol-Myers Squibb Company, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Guardant Health, Inc., healthOme, Inc., Hitachi High-Tech Corporation, Illumina, Inc., Johnson & Johnson, Laboratory Corporation of America Holdings, Medtronic PLC, Merck KGaA, N-Power Medicine, Inc., Natera Inc., NeoGenomics, Inc., Novartis AG, Pfizer, Inc., Precision Medicine Group, LLC, QIAGEN N.V., Quest Diagnostics Incorporated, Sanofi SA, Strata Oncology, Inc., Tempus AI, Inc., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and ZS Associates, Inc.. Actionable Recommendations for Navigating the Future of Precision Medicine

Industry leaders are encouraged to adopt a forward-thinking approach that leverages emerging technologies and data-driven methodologies to bridge the gap between current capabilities and future needs. One key recommendation is the investment in state-of-the-art diagnostic infrastructure that integrates genomic sequencing, artificial intelligence, and advanced analytics. By harnessing these tools, organizations can ensure that their diagnostic processes are both accurate and timely, thus facilitating early intervention and personalized treatment.

It is essential to cultivate strategic partnerships that merge expertise across academic research, clinical practice, and technological innovation. Such alliances not only enhance the scope of available resources but also enable a more agile response to regulatory changes and market dynamics. Leaders should also prioritize the development of cross-functional teams that blend clinical insights with data science expertise, ensuring that new products and services are both clinically effective and commercially viable.

Another key recommendation involves the adoption of flexible business models that can adapt to the rapid pace of technological change. Embracing digital transformation is vital, particularly through the integration of innovative software and data analytics tools into everyday clinical operations. This proactive stance will enable organizations to seamlessly incorporate emerging evidence and best practices into their business strategies, paving the way for sustained competitive advantage.

Furthermore, a focus on patient-centric outcomes is crucial. Leaders must ensure that every strategic decision is informed by a commitment to improving patient care quality, which ultimately translates into higher satisfaction and better health outcomes. This may involve reconfiguring service delivery models to include remote monitoring, telehealth services, and personalized care plans that reflect the latest advances in precision medicine.

Finally, continuous education and training initiatives should be implemented to keep the workforce abreast of the latest technological trends and regulatory updates. By fostering an environment of ongoing learning, companies can empower their teams to innovate and adapt, ensuring that the organization remains at the cutting edge of precision medicine innovation.

Conclusion: Embracing a Future Driven by Precision Medicine Innovations

Precision medicine is redefining the boundaries of healthcare with its promise of individualized treatment and targeted therapies. The evolving landscape, marked by groundbreaking technological innovations, dynamic segmentation strategies, and significant regional and corporate contributions, is building a foundation for a healthcare system that is more responsive, efficient, and patient-focused.

This comprehensive analysis has uncovered the transformative shifts that are reshaping both diagnostics and therapeutics, highlighted the critical insights gathered from detailed market segmentation, and illuminated the global regional dynamics that are setting the course for future developments. The role of pioneering companies in driving innovation and forging strategic partnerships demonstrates the collaborative nature of this field, underscoring the need for continuous investment in research, technology, and human capital.

As stakeholders continue to push the envelope of what is possible, it is imperative to remain vigilant and adaptive. The future of precision medicine is not determined solely by scientific breakthroughs but also by an integrated approach that combines technology, regulation, and clinical excellence. The convergence of these elements promises a future where healthcare is not just about treating disease but about enhancing quality of life.

Ultimately, the journey toward a more precise and personalized healthcare model is one of both immense promise and significant challenge. It is a call to action for all industry players to harness the momentum of current innovations and channel it into strategies that drive sustained growth, improved patient outcomes, and an overall transformation of the global healthcare landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases with demand for personalized treatment options
      • 5.1.1.2. Growing awareness among patients and healthcare providers about the benefits of precision medicine
      • 5.1.1.3. Increased government initiatives and public-private funding aimed at advancing precision medicine technologies
    • 5.1.2. Restraints
      • 5.1.2.1. High development cost and lack standardized protocols and guidelines for precision medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence into precision medicine for improved patient diagnosis and therapy
      • 5.1.3.2. Collaborations between market vendors and research institutes to advance precision medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with privacy and the confidentiality of personal and health information of patients
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Foundational role in accurately identifying the molecular and genetic underpinnings of disease increases usage of diagnostics
    • 5.2.2. Application: Widepread usage of precision medicine in oncology due to its ability to tailor therapeutic approaches based on individual genetic, molecular, and clinical profiles
    • 5.2.3. End User: Adoption of precision medicine in biopharmaceutical & biotechnology companies to develop targeted therapies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Precision Medicine Market, by Product Type

  • 6.1. Introduction
  • 6.2. Diagnostics
    • 6.2.1. Companion Diagnostics
    • 6.2.2. Genetic Testing
    • 6.2.3. Liquid Biopsy
    • 6.2.4. Molecular Diagnostics
    • 6.2.5. Point-of-Care Testing
  • 6.3. Software & Data Analytics
  • 6.4. Therapeutics
    • 6.4.1. Cell Therapy
    • 6.4.2. Gene Therapy
    • 6.4.3. Immunotherapy
    • 6.4.4. Protein Replacement Therapy
    • 6.4.5. RNA-Based Therapy
    • 6.4.6. Targeted Therapy

7. Precision Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Diseases
  • 7.3. Cardiology
  • 7.4. Infectious Diseases
  • 7.5. Neurology
  • 7.6. Oncology
  • 7.7. Rare & Genetic Disorders
  • 7.8. Respiratory Diseases

8. Precision Medicine Market, by End User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical & Biotechnology Companies
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals & Clinics
  • 8.5. Research Institutes

9. Americas Precision Medicine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Precision Medicine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Precision Medicine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. FPNV Positioning Matrix, 2024
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. MB Therapeutics secures Euro 2 million in seed funding to accelerate research and enhance personalized medicine production
    • 12.3.2. Caris Life Sciences announces a strategic collaboration with Ontada to advance oncology research and the adoption of precision medicine
    • 12.3.3. Lupus Research Alliance launches DREAM platform to advance precision medicine
    • 12.3.4. Hitachi High-Tech and Gencurix unite to commercialize advanced cancer molecular diagnostics, accelerating precision medicine
    • 12.3.5. WashU Medicine's Center for Translational Bioinformatics to enhance personalized precision medicine and clinical trials through cutting-edge innovation
    • 12.3.6. Precision for Medicine acquires Algorics to integrate MetaVate and Clarity for enhanced clinical trial execution
    • 12.3.7. Karolinska Institutet, Karolinska University Hospital, and Elekta forge a strategic alliance to transform cancer care through precision diagnostics
    • 12.3.8. Genomic Medicine Sweden receives SEK 49.5 million for precision medicine investments
    • 12.3.9. Siemens Healthineers and IISc launch state-of-the-art AI laboratory to transform precision medicine
    • 12.3.10. BIOS Health partners with local authorities and Kern Venture Group to launch a West Coast precision medicine centre in Bakersfield
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Novartis AG
    • 12.4.2. Illumina, Inc.
    • 12.4.3. Tempus AI, Inc.
    • 12.4.4. Caris Life Sciences

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Amgen Inc.
  • 3. Aranscia, LLC
  • 4. AstraZeneca PLC
  • 5. biocrates life sciences ag
  • 6. bioMerieux S.A.
  • 7. Bristol-Myers Squibb Company
  • 8. Caris Life Sciences
  • 9. Exact Sciences Corporation
  • 10. F. Hoffmann-La Roche AG
  • 11. Gilead Sciences, Inc.
  • 12. Guardant Health, Inc.
  • 13. healthOme, Inc.
  • 14. Hitachi High-Tech Corporation
  • 15. Illumina, Inc.
  • 16. Johnson & Johnson
  • 17. Laboratory Corporation of America Holdings
  • 18. Medtronic PLC
  • 19. Merck KGaA
  • 20. N-Power Medicine, Inc.
  • 21. Natera Inc.
  • 22. NeoGenomics, Inc.
  • 23. Novartis AG
  • 24. Pfizer, Inc.
  • 25. Precision Medicine Group, LLC
  • 26. QIAGEN N.V.
  • 27. Quest Diagnostics Incorporated
  • 28. Sanofi SA
  • 29. Strata Oncology, Inc.
  • 30. Tempus AI, Inc.
  • 31. Teva Pharmaceutical Industries Ltd.
  • 32. Thermo Fisher Scientific Inc.
  • 33. ZS Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. PRECISION MEDICINE MARKET MULTI-CURRENCY
  • FIGURE 2. PRECISION MEDICINE MARKET MULTI-LANGUAGE
  • FIGURE 3. PRECISION MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 4. PRECISION MEDICINE MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 15. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 17. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 23. PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PRECISION MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECISION MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECISION MEDICINE MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECISION MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECISION MEDICINE MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECISION MEDICINE MARKET SIZE, BY SOFTWARE & DATA ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECISION MEDICINE MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECISION MEDICINE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PRECISION MEDICINE MARKET SIZE, BY PROTEIN REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECISION MEDICINE MARKET SIZE, BY RNA-BASED THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PRECISION MEDICINE MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PRECISION MEDICINE MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PRECISION MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PRECISION MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PRECISION MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PRECISION MEDICINE MARKET SIZE, BY RARE & GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PRECISION MEDICINE MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PRECISION MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PRECISION MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. TAIWAN PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. THAILAND PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. VIETNAM PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. DENMARK PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. EGYPT PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. FINLAND PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. FRANCE PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. GERMANY PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. ISRAEL PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. ITALY PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. NIGERIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. NORWAY PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. POLAND PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. QATAR PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. RUSSIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SPAIN PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. SWEDEN PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. TURKEY PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 247. PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024